Promega Corporation
Home » Resources » Protocols »

CaspACE™ FITC-VAD-FMK In Situ Marker Product Information

Video

Apoptosis Overview Animation ThumbnailLearn the fundamentals of apoptosis with this animated presentation

Literature # 9PIG746

CaspACE™ FITC-VAD-FMK In Situ Marker is a fluoroisothiocyanate (FITC) conjugate of the cell permeable caspase inhibitor VAD-FMK. This structure allows delivery of the inhibitor into the cell where it binds to activated caspase, serving as an in situ marker for apoptosis. The bound marker is localized by fluorescence detection.

Printed in USA. Revised 4/13.

PDF Icon Complete Protocol PDF (79kb)

Promega

Wir über uns

Connect With Us

Prefer a different language?

Your country is set to Germany. Your language is set to Deutsch. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

  • Warning
  • It appears that you have Javascript disabled. Our website requires Javascript to function correctly. Please enable Javascript to experience our website.